Company / Current Assets
Beam Therapeutics Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.3B
FY2025
5-year range
$878.1M / $1.3B
FY2021-FY2025
Trend
+44.5%
vs FY2024
Sector context
#41 of 213
Health Care
What the data says
Beam Therapeutics Inc.'s current assets of $1.3B is higher than 81% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 7 years, ranging from $95M in FY2019 to $1.3B in FY2021.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +32.7%. Top quartile in the Health Care sector.
Improved from $1.2B to $1.3B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +5.1%
- 5-Year CAGR
- +32.7%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 213This company $1.3B Sector average $2.5B
▼
-49.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.7%, indicating consistent growth.
- In FY2025, current assets increased 44.5% year-over-year.
- Ranks #41 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +44.5% |
| FY2024 | $878.1M | -27.5% |
| FY2023 | $1.2B | +10.8% |
| FY2022 | $1.1B | -14.1% |
| FY2021 | $1.3B | +312.9% |
| FY2020 | $308.3M | +226.1% |
| FY2019 | $94.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026